Published in Physiol Res on January 01, 2001
Differential effects of alendronate and losartan therapy on osteopenia and aortic aneurysm in mice with severe Marfan syndrome. Hum Mol Genet (2010) 1.03
Captopril improves osteopenia in ovariectomized rats and promotes bone formation in osteoblasts. J Bone Miner Metab (2010) 0.83
The effects of antihypertensive drugs on bone mineral density in ovariectomized mice. J Korean Med Sci (2013) 0.76
Functional Local Renin-Angiotensin System in Human and Rat Periodontal Tissue. PLoS One (2015) 0.75
[Ferritin, oxidative stress and coronary atherosclerosis]. Vnitr Lek (2004) 2.08
[Clinical spectrum of the antiphospholipid syndrome]. Cas Lek Cesk (1997) 1.39
Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Physiol Res (2002) 1.31
Porphyrinogens in urine in various types of porphyrias. J Clin Chem Clin Biochem (1982) 1.08
Ethanol and oxidative stress. Alcohol Clin Exp Res (2001) 1.07
Long-term outcome of severe alveolar haemorrhage in ANCA-associated vasculitis: a retrospective cohort study. Scand J Rheumatol (2013) 1.05
Primary Sjögren's syndrome in children and adolescents: proposal for diagnostic criteria. Clin Exp Rheumatol (1999) 1.00
Trace elements in hemodialysis and continuous ambulatory peritoneal dialysis patients. Blood Purif (1998) 0.92
Trace elements in end-stage renal disease. 2. Clinical implication of trace elements. Blood Purif (1999) 0.92
Acute renal failure due to bilateral renal artery thrombosis associated with primary antiphospholipid syndrome. Nephrol Dial Transplant (1998) 0.92
Exposure to silica and risk of ANCA-associated vasculitis. Am J Ind Med (2006) 0.92
Culture methods of glomerular podocytes. Kidney Blood Press Res (2007) 0.91
[Diabetes, dyslipidaemia and kidney diseases]. Vnitr Lek (2008) 0.91
Antibodies against oxidized LDL--theory and clinical use. Physiol Res (2001) 0.90
Deoxyspergualin in relapsing and refractory Wegener's granulomatosis. Ann Rheum Dis (2008) 0.90
The effect of quinolinate on rat brain lipid peroxidation is dependent on iron. Neurochem Int (1997) 0.90
Fibroblast growth factor 23 and matrix-metalloproteinases in patients with chronic kidney disease: are they associated with cardiovascular disease? Kidney Blood Press Res (2009) 0.89
Antioxidant enzymes and lipid peroxidation in patients with multiple myeloma. Neoplasma (1996) 0.89
Comparison of different immunoassays for CA 19-9. Clin Chem Lab Med (2001) 0.88
Cytokine profile in autosomal dominant polycystic kidney disease. Biochem Mol Biol Int (1997) 0.88
Mechanisms of chronic heart failure development in end-stage renal disease patients on chronic hemodialysis. Physiol Res (2008) 0.88
Relationship of soluble RAGE and RAGE ligands HMGB1 and EN-RAGE to endothelial dysfunction in type 1 and type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes (2012) 0.88
Impact of risk factors on prevalence of anal HPV infection in women with simultaneous cervical lesion. Neoplasma (2015) 0.87
Soluble TNF and IL-2 receptors in patients with breast cancer. Med Sci Monit (2001) 0.87
Relationship of pregnancy-associated plasma protein-a to renal function and dialysis modalities. Kidney Blood Press Res (2004) 0.86
The binding of protoporphyrin to serum proteins. Clin Chim Acta (1973) 0.86
[Urinary tract infection in patients with diabetes mellitus]. Vnitr Lek (2006) 0.86
Cyclosporine A or intravenous cyclophosphamide for lupus nephritis: the Cyclofa-Lune study. Lupus (2010) 0.86
Influence of plasma exchange on serum levels of cytokines and adhesion molecules in ANCA-positive renal vasculitis. Blood Purif (1998) 0.85
Porphyrinogens in plasma. Arch Dermatol (1982) 0.85
[The production and properties of human immunoglobulin G-anti-D (Halle)]. Dtsch Gesundheitsw (1970) 0.85
Levels of circulating biomarkers at rest and after exercise in coronary artery disease patients. Physiol Res (2009) 0.85
Leptin and adiponectin in pancreatic cancer: connection with diabetes mellitus. Neoplasma (2011) 0.84
Oxidative stress and inflammation in pregnancy. Scand J Clin Lab Invest (2006) 0.84
Influence of endothelin-1 gene polymorphisms on the progression of autosomal dominant polycystic kidney disease. Kidney Blood Press Res (2006) 0.84
Immunohistochemistry and serum values of S-100B, glial fibrillary acidic protein, and hyperphosphorylated neurofilaments in brain injuries. Soud Lek (2012) 0.84
Role of endothelin and nitric oxide in the pathogenesis of arterial hypertension in autosomal dominant polycystic kidney disease. Physiol Res (2003) 0.84
Clinical features and natural history of IgA nephropathy. Ann Med Interne (Paris) (1999) 0.84
Carbonyl and oxidative stress in patients with breast cancer--is there a relation to the stage of the disease? Neoplasma (2007) 0.84
Transjugular renal biopsy. Our experience with 67 cases. Kidney Blood Press Res (2001) 0.84
Chromium levels in patients with internal diseases. Biochem Mol Biol Int (1998) 0.83
ICRF-187 (dexrazoxan) protects from adriamycin-induced nephrotic syndrome in rats. Nephrol Dial Transplant (1998) 0.83
Incomplete distal renal tubular acidosis coinherited with a mutation in the band 3 (AE1) gene. Nephrol Dial Transplant (1997) 0.83
Lipid peroxidation and superoxide dismutase activity in umbilical and maternal blood. Biochem Mol Biol Int (1995) 0.83
Decreased levels of advanced glycation end-products in patients with Gilbert syndrome. Cell Mol Biol (Noisy-le-grand) (2005) 0.83
A novel method for the estimation of podocyte injury: podocalyxin-positive elements in urine. Folia Biol (Praha) (2008) 0.83
Renal AA amyloidosis: survey of epidemiologic and laboratory data from one nephrology centre. Int Urol Nephrol (2009) 0.82
Regulation of diurnal variation of cholesterol 7alpha-hydroxylase (CYP7A1) activity in healthy subjects. Physiol Res (2009) 0.82
Influence of the alpha-adducin and ACE gene polymorphism on the progression of autosomal-dominant polycystic kidney disease. Kidney Blood Press Res (2003) 0.82
Current therapeutic possibilities in primary and secondary amyloidosis and our experience with 31 patients. Nephrol Dial Transplant (2003) 0.82
Genetic basis of nephrotic syndrome--review. Prague Med Rep (2006) 0.81
Event-related potentials in evaluation of metabolic encephalopathies. Schweiz Arch Neurol Psychiatr (1993) 0.80
Chronic endothelin receptor blockade reduces end-organ damage independently of blood pressure effects in salt-loaded heterozygous Ren-2 transgenic rats. Physiol Res (2004) 0.80
Effect of acute hyperglycaemia on selected plasma and urinary cytokine antagonists in Type 1 diabetes mellitus. Diabetologia (2003) 0.80
[Lipid peroxidation and activity of antioxidative enzymes in patients with multiple myeloma]. Cas Lek Cesk (1996) 0.80
Hepatic biotransformation in rodents and physicochemical properties of 23(R)-hydroxychenodeoxycholic acid, a natural alpha-hydroxy bile acid. J Lipid Res (1996) 0.80
Photodynamic therapy of cutaneous metastases of breast cancer after local application of meso-tetra-(para-sulphophenyl)-porphin (TPPS4). J Photochem Photobiol B (1996) 0.80
Pregnancy-associated plasma protein-A in patients with cerebrovascular diseases--a pilot study. Prague Med Rep (2006) 0.80
Inflammatory cytokine profile in autosomal dominant polycystic kidney disease. Contrib Nephrol (1997) 0.80
The effect of the irradiation wavelength on the processes sensitized by protoporphyrin IX dimethyl ester. Radiat Res (1997) 0.80
Miotic action of tramadol is determined by CYP2D6 genotype. Physiol Res (2006) 0.80
Genetic variation screening of TNNT2 gene in a cohort of patients with hypertrophic and dilated cardiomyopathy. Physiol Res (2012) 0.80
Recent insights into the pathogenesis of nephrotic syndrome. Minerva Med (2013) 0.79
Skin autofluorescence relates to soluble receptor for advanced glycation end-products and albuminuria in diabetes mellitus. J Diabetes Res (2013) 0.79
Agents affecting porphyrin formation and secretion: implications for porphyria cutanea treatment. Semin Hematol (1989) 0.79
Role of common canalicular transporter gene variations in aetiology of idiopathic gallstones in childhood. Folia Biol (Praha) (2010) 0.79
Comparison of three methods for determination of glucose. Prague Med Rep (2010) 0.79
Trace elements in end-stage renal disease. 1. Methodological aspects and the influence of water treatment and dialysis equipment. Blood Purif (1999) 0.79
The use and possible diagnostic significance of sephadex gel filtration of serum from icteric newborn. Biol Neonat (1967) 0.79
Preeclampsia, dilated cardiomyopathy and renal failure as the first manifestation of systemic lupus erythematosus: a case report. Clin Rheumatol (2008) 0.79
Hyperbaric oxygen and photodynamic therapy in tumour-bearing nude mice. Eur J Cancer (1991) 0.79
Differential linkage of triglyceride and glucose levels on rat chromosome 4 in two segregating rat populations. Folia Biol (Praha) (2003) 0.79
Preparation, properties and metabolism of iodinated bromosulphthalein. Nature (1966) 0.79
[Disorders of urinary acidification in patients with monoclonal gammapathies]. Cas Lek Cesk (2000) 0.79
The influence of cyclosporin on lipid peroxidation and superoxide dismutase in adriamycin nephropathy in rats. Nephron (1997) 0.79
The effect of silibinin on experimental cyclosporine nephrotoxicity. Ren Fail (1998) 0.78
Methods for detection of circulating tumour cells and their clinical value in cancer patients. Folia Biol (Praha) (2011) 0.78
ANCA-associated renal vasculitis--epidemiology, diagnostics and treatment. Prague Med Rep (2004) 0.78
Effects of Doxorubicin (Adriamycin) and [(+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)]propane (ICRF-187) on skeletal muscle protease activities. Toxicol Appl Pharmacol (2001) 0.78
Daily oral versus pulse intravenous cyclophosphamide in the therapy of ANCA-associated vasculitis--preliminary single center experience. Prague Med Rep (2004) 0.78
Brain diffuse large B-cell lymphoma in a systemic lupus erythematosus patient treated with immunosuppressive agents including mycophenolate mofetil. Lupus (2011) 0.78
Long-term treatment of IgA nephropathy with cyclosporin A--a preliminary report. Nephrol Dial Transplant (1997) 0.78
Advanced glycoxidation end products in patients with multiple sclerosis. Prague Med Rep (2005) 0.78
Treatment of early diagnosed HCV infection in hemodialyzed patients with interferon-alpha. Treatment of hepatitis C. Blood Purif (2004) 0.78